- On this page:
Information related to relevant oppositions from around the world.
The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.
Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.
|Country||Date||Who Filed||Opposition type||Opposition status||Patent type||Related patent application||More info|
|United States||23-03-2015||Apotex Corp||Review||Parties mutually agreed to settle and terminate the IPR (inter partes review). PTAB (Patent Trial and Appeal Board) Terminated the review proceedings||Combination||US6417191||View/Comment|
Is something missing? Help us by contributing missing data: Contribute